Cvrx Inc (CVRX) Stock Price, Quote & News

Latest News on CVRX

Feb 12, 2025, 2:45 PM EST - 7 weeks ago

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

Feb 4, 2025, 11:00 PM EST - 2 months ago

CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript

Feb 4, 2025, 4:05 PM EST - 2 months ago

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Jan 21, 2025, 4:30 PM EST - 2 months ago

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

Dec 23, 2024, 4:30 PM EST - 3 months ago

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 20, 2024, 4:30 PM EST - 4 months ago

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 6, 2024, 9:04 PM EST - 5 months ago

CVRx: Impressive Top-Line Growth Seems Priced In

Oct 29, 2024, 10:38 PM EDT - 5 months ago

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

Oct 18, 2024, 2:08 PM EDT - 5 months ago

CVRx announces new CPT® Category I codes for Barostim

Oct 15, 2024, 4:30 PM EDT - 6 months ago

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

Sep 3, 2024, 8:30 AM EDT - 7 months ago

CVRx Announces Appointment of Two New Board Members

Aug 19, 2024, 4:00 PM EDT - 8 months ago

CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Aug 19, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join

Aug 18, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Is Seeking CVRx Inc Shareholders To Join Fraud Investigation

Aug 17, 2024, 11:00 AM EDT - 8 months ago

CVRx Inc Shareholders Can Join Fraud Investigation With The Schall Law Firm

Aug 16, 2024, 11:00 AM EDT - 8 months ago

CVRx Inc Investors Encouraged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 15, 2024, 11:00 AM EDT - 8 months ago

CVRx Inc Shareholders Urged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 14, 2024, 10:30 PM EDT - 8 months ago

CVRx Inc Shareholders Invited To Join Fraud Inquiry With The Schall Law Firm

Aug 14, 2024, 12:30 AM EDT - 8 months ago

CVRx Inc Investors May Participate In Fraud Investigation With The Schall Law Firm

Aug 13, 2024, 2:00 AM EDT - 8 months ago

CVRx Inc Investors Urged To Join The Fraud Investigation With The Schall Law Firm

Aug 9, 2024, 8:30 PM EDT - 8 months ago

CVRx Inc Investors Encouraged to Participate in Fraud Investigation With The Schall Law Firm

Aug 8, 2024, 4:00 PM EDT - 8 months ago

CVRx Inc Investors Can Join Fraud Investigation With The Schall Law Firm

Aug 7, 2024, 4:15 PM EDT - 8 months ago

CVRx Inc Investors Are Eligible To Join Fraud Investigation With The Schall Law Firm

Aug 6, 2024, 3:30 PM EDT - 8 months ago

CVRx Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

Aug 5, 2024, 11:00 AM EDT - 8 months ago

CVRX Investors Have Opportunity to Join CVRx, Inc. Fraud Investigation with the Schall Law Firm

Aug 2, 2024, 8:00 AM EDT - 8 months ago

CVRx Announces Increased Inpatient Payment for Barostim Procedure

Jul 31, 2024, 4:27 PM EDT - 8 months ago

CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 29, 2024, 7:56 PM EDT - 8 months ago

CVRx, Inc. (CVRX) Q2 2024 Earnings Call Transcript

Jul 29, 2024, 4:05 PM EDT - 8 months ago

Market Cap	326.23M
Revenue (ttm)	51.29M
Net Income (ttm)	-59.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-116.92%
Debt to Equity Ratio	0.69

Volume	162,300
Avg Vol	222,266
Day's Range	N/A - N/A
Shares Out	26.04M
Stochastic %K	77%
Beta	1.33
Analysts	Strong Sell
Price Target	$19.83